Reducing Opioid Overdose Mortality: Role of Community-Administered Naloxone
Tell a Friend About This EventTell a Friend

When: June 23rd
9:00 AM until 10:30 AM

« Go to Upcoming Event List  

Reducing Opioid Overdose Mortality:

 Role of Community-Administered Naloxone


A Live Webcast Sponsored by:

 Opioid Post-Marketing Requirements Consortium (OPC)/Campbell Alliance (Purdue Pharma, LP; Actavis; Endo Pharmaceuticals; Janssen Pharmaceuticals; Mallinckrodt, LLC; Pfizer; Rhodes Pharmaceuticals, LP; Roxane Laboratories; and Zogenix), Clinical Directors Network, Inc.(CDN), N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667)

This webcast is pending for up to 1.5 Prescribed credits by the American Academy of Family Physicians (AAFP)



Membership Software Powered by YourMembership  ::  Legal